Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment:a nationwide cohort study in the Netherlands
BACKGROUND: Development of skin cancer, in particular melanoma, has been linked to sex hormones. We aimed to determine the incidence of skin cancer in transgender individuals receiving gender-affirming hormone treatment (GAHT). METHODS: In this nationwide retrospective cohort study, clinical information of participants who visited our clinic between (the years) 1972 and 2018 and received GAHT was integrated with national pathology and cancer statistics data in order to assess skin cancer incidence. Standardized incidence ratios (SIRs) were calculated. RESULTS: The cohort consisted of 2,436 tra... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2023 |
| Reihe/Periodikum: | Rahmat , A , De Nie , I , Wiepjes , C M , Den Heijer , M , Rustemeyer , T , De Blok , C J M & Dreijerink , K M A 2023 , ' Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment : a nationwide cohort study in the Netherlands ' , International Journal of Dermatology , vol. 62 , no. 7 , pp. 882-887 . https://doi.org/10.1111/ijd.16707 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-27232685 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://research.vumc.nl/en/publications/1fe49297-edef-4ec6-9706-130faf00bca0 |
